Takeda Barred From Doubling Up Patent Claims In Drug Case
A California federal judge has tossed Takeda Pharmaceutical Co. Ltd.'s claim seeking declaratory judgment that Mylan Inc.'s planned generic version of the acid reflux drug Dexilant will infringe its patents, saying...To view the full article, register now.
Already a subscriber? Click here to view full article